麗珠醫藥(01513.HK):選舉汪卯林為監事長
格隆匯 6 月 30日丨麗珠醫藥(01513.HK)發佈公告,現任公司第九屆監事會的職工代表監事汪卯林已在2020年6月29日舉行的職工代表大會上重獲當選為公司第十屆監事會的職工代表監事。公司第十屆監事會另外兩名股東代表監事已在2020年6月30日舉行的二零二零年第三次臨時股東大會上選舉產生,已獲重選的兩名股東代表監事,即黃華敏和湯胤,將與職工代表監事汪卯林同為公司第十屆監事會的成員。
2020年6月30日,公司第十屆監事會第一次會議選舉汪卯林為公司第十屆監事會監事長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.